UNII 4ELV7Z65AP

STEARIC ACID

Unique Ingredient Identifier 4ELV7Z65AP is listed as a ingredient substance

• RN: 57-11-4
• EC: 200-313-4
• NCIT: C68426
• RXCUI: 1310551
• PUBCHEM: 5281
• MF: C18H36O2
• INCHI KEY: QIQXTHQIDYTFRH-UHFFFAOYSA-N
• SMILES: CCCCCCCCCCCCCCCCCC(O)=O

Dosage Forms

UNII 4ELV7Z65AP STEARIC ACID is commonly included in medications in the following forms.

Route	Dosage Form	Potency
BUCCAL	TABLET	5 MG
BUCCAL/SUBLINGUAL	TABLET	6 MG
IMPLANTATION	PELLET	0.2 MG
ORAL	CAPSULE	52 MG
ORAL	CAPSULE, COATED, SOFT GELATIN	3 MG
ORAL	CAPSULE, DELAYED ACTION	3 MG
ORAL	CAPSULE, EXTENDED RELEASE	3.23 MG
ORAL	CAPSULE, HARD GELATIN	15 MG
ORAL	CAPSULE, SUSTAINED ACTION	21 MG
ORAL	POWDER, FOR SUSPENSION	1203 MG/5ML
ORAL	SYRUP	NA
ORAL	TABLET	72 MG
ORAL	TABLET (IMMED./COMP. RELEASE), COATED	5.3 MG
ORAL	TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	15 MG
ORAL	TABLET, CHEWABLE	10 MG
ORAL	TABLET, COATED	42.4 MG
ORAL	TABLET, CONTROLLED RELEASE	1.6 MG
ORAL	TABLET, DELAYED ACTION	20 mg
ORAL	TABLET, DELAYED ACTION, ENTERIC COATED	16 MG
ORAL	TABLET, DELAYED RELEASE	20 mg
ORAL	TABLET, ENTERIC COATED PARTICLES	5 MG
ORAL	TABLET, EXTENDED RELEASE	180 MG
ORAL	TABLET, FILM COATED	22 MG
ORAL	TABLET, ORALLY DISINTEGRATING	10 MG
ORAL	TABLET, SUGAR COATED	0.9 MG
ORAL	TABLET, SUSTAINED ACTION	187.5 MG
ORAL	TABLET, SUSTAINED RELEASE, FILM COATED	9 MG
SUBCUTANEOUS	IMPLANT	1.04 MG
SUBLINGUAL	TABLET	5.05 MG
TOPICAL	CREAM, AUGMENTED	3 %W/W
TOPICAL	CREAM, EMULSION, SUSTAINED RELEASE	16 %W/W
TOPICAL	EMULSION, AEROSOL FOAM	8 %W/W
TOPICAL	EMULSION, CREAM	22.5 %W/W
TOPICAL	EMULSION, CREAM	5 %W/W
TOPICAL	LOTION	2 %W/W
TOPICAL	OINTMENT	15 %W/W
TOPICAL	SOLUTION	NA
TOPICAL	SUSPENSION	1.75 %W/W
VAGINAL	EMULSION, AEROSOL FOAM	4 %
VAGINAL	EMULSION, CREAM	14 %
VAGINAL	TABLET	60 MG